Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:16 PM
Ignite Modification Date:
2025-12-24 @ 2:16 PM
NCT ID:
NCT00984295
Eligibility Criteria:
Inclusion Criteria:
* In good health
* Negative clinical history of varicella, zoster, measles, mumps, rubella, diptheria, tetanus, pertussis, invasive Hib disease and hepatitis B
* Had completed either a 2-dose primary series of PedvaxHIB or COMVAX or any 3-dose primary series of a licensed Hib vaccine
* Had received 2 or 3 doses of any hepatitis B vaccine or COMVAX prior to entry into trial
Exclusion Criteria:
* Previous receipt of measles, mumps, rubella or varicella vaccine either alone or in combination
* Any immune impairment or deficiency
* Recent household, daycare or school exposure to invasive Hib disease or hepatitis B
* Exposure to measles, mumps, rubella, varicella, or zoster in the 4 weeks prior to vaccination
* Vaccination with an inactive vaccine with in the past 14 days
* Vaccination with a live vaccine within the past 30 days
* Receipt of immune globulin, blood transfusion or blood-derived product in the past 3 months
* Recent history of fever or underlying medical problems
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
12 Months
Maximum Age:
15 Months
Study:
NCT00984295
Study Brief:
Protocol Section:
NCT00984295